Stockscreener 앱 받기
0.7258
2.75%
-0.0205
시장 영업 전:
.74
0.0142
+1.96%
전일 마감가:
$0.7463
열려 있는:
$0.731
하루 거래량:
504.81K
Relative Volume:
0.68
시가총액:
$76.97M
수익:
$15.33M
순이익/손실:
$-34.78M
주가수익비율:
-1.7759
EPS:
-0.4087
순현금흐름:
$-28.66M
1주 성능:
-3.84%
1개월 성능:
-8.13%
6개월 성능:
-43.30%
1년 성능:
-41.94%
1일 변동 폭
$0.00
$0.00
1주일 범위
$0.705
$0.7812
52주 변동 폭
$0.705
$1.935
Hyperfine Inc Stock (HYPR) Company Profile
명칭
Hyperfine Inc
전화
866-796-6767
주소
351 NEW WHITFIELD STREET, GUILFORD
Compare HYPR vs ABT, MDT, SYK, BSX, EW
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
HYPR
Hyperfine Inc
|
0.7258 | 76.97M | 15.33M | -34.78M | -28.66M | -0.4087 |
ABT
Abbott Laboratories
|
102.51 | 177.38B | 46.59B | 5.41B | 7.38B | 3.0938 |
MDT
Medtronic Plc
|
96.59 | 123.55B | 36.36B | 4.84B | 5.43B | 3.7261 |
SYK
Stryker Corp
|
307.08 | 117.79B | 25.27B | 3.34B | 4.57B | 8.6334 |
BSX
Boston Scientific Corp
|
46.01 | 66.68B | 20.62B | 3.56B | 3.48B | 2.3847 |
EW
Edwards Lifesciences Corp
|
90.09 | 51.93B | 6.30B | 1.07B | 1.09B | 1.8406 |
Hyperfine Inc Stock (HYPR) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2026-04-29 | 개시 | BTIG Research | Buy |
| 2022-08-11 | 다운그레이드 | Wells Fargo | Overweight → Equal Weight |
| 2022-05-31 | 개시 | Evercore ISI | Outperform |
| 2022-04-14 | 개시 | Wells Fargo | Overweight |
Hyperfine Inc 주식(HYPR)의 최신 뉴스
Preliminary Q3 revenue rises 55% year over year at Hyperfine (HYPR), topping net cash burn for the first time. - Stock Titan
Hyperfine Reports Record Preliminary Third Quarter Revenue of Approximately $6.0 Million & Reaffirms Full Year 2026 Revenue Outlook of Approximately $20 to $22 Million - Business Wire
Hyperfine Receives Nasdaq Minimum Bid Price Deficiency Notice - TipRanks
Lioness Medtech Showcasing Hyperfine Swoop at Röntgenveckan 2026 - marketscreener.com
HYPR Financials: Revenue Breakdown, Margins & Competitor Comparison - Intellectia AI
Hyperfine (HYPR) Holds at $0.81, Pressing Against Support After Mild PullbackMarket Neutral Pair - siam.in
Hyperfine Forms Global Neurosurgery Advisory Council - Medical Product Outsourcing
Hyperfine, Inc. to Participate in Lake Street Capital Markets 10th Annual Best Ideas Growth Conference - Yahoo Finance
Outset Medical, Inc. (OM) Stock Price & News - Syfe
Hyperfine reports 3,000 scans completed in first office year By Investing.com - Investing.com Nigeria
Hyperfine reports 3,000 scans completed in first office year By Investing.com - Investing.com Canada
Hyperfine reports 3,000 scans completed in first office year - investing.com
Hyperfine (HYPR) Earnings Update: The Available Earnings Metric Delivers a Beat at the Close; Market Response: Shares Finish 4.21% Down for the Current SessionEnergy Earnings Report - vinanet.vn
HYPR | Hyperfine, Inc. Class A FinancialsRevenue Breakdown - Quiver Quantitative
BTIG reiterates Hyperfine stock rating on FDA software clearance By Investing.com - Investing.com Canada
BTIG reiterates Hyperfine stock rating on FDA software clearance - Investing.com
Hyperfine Wins FDA Clearance for Next Optive AI Software - Medical Product Outsourcing
Hyperfine receives FDA clearance for Swoop MRI software update - Investing.com
Hyperfine receives FDA clearance for Swoop MRI software update By Investing.com - Investing.com South Africa
Hyperfine receives FDA clearance for Swoop MRI software update By Investing.com - Investing.com Nigeria
Hyperfine receives FDA clearance for Swoop MRI software update By Investing.com - Investing.com Canada
Hyperfine receives FDA clearance for Swoop MRI software update By Investing.com - Investing.com India
Hyperfine Announces FDA Clearance of the Next Optive AI™ Software, Further Enhancing Image Quality, Clinical Utility, and Ease of Use of the Swoop® System Across Care Settings - Business Wire
Hyperfine, Inc. (NASDAQ:HYPR) Receives Consensus Recommendation of "Hold" from Brokerages - MarketBeat
Hyperfine Inc. (HYPR) Q2 2026 Earnings: Narrower Loss Beats Estimates, Shares Edge LowerEarnings Momentum Score - vinanet.vn
Hyperfine Inc. (HYPR) Q2 2026 Earnings: Narrower Loss Beats Estimates, Shares Edge LowerGrowth Acceleration Report - dars.gov.et
HYPR Q2 2026 Earnings: Narrower Loss Beats Estimates as Shares SlipEarnings Stability Report - vinanet.vn
Hyperfine (HYPR) Q2 2026 Earnings Call Transcript - AOL.com
Hyperfine Inc. (HYPR) Edges Lower to $0.9 as Shares Trade Within Narrow RangeLiquidity Order Flow - vinanet.vn
Hyperfine Inc. (HYPR) Edges Lower to $0.9 as Shares Trade Within Narrow RangeJelly Roll Trade - dars.gov.et
Hyperfine Inc. (HYPR) Edges Lower to $0.9 as Shares Trade Within Narrow RangeSmart Money Flow Stocks - siam.in
Hyperfine, Inc. 2026 Q2ResultsEarnings Call Presentation (NASDAQ:HYPR) 2026-08-10 - Seeking Alpha
HYPR Reiterates by B. Riley Securities -- Price Target Lowers to $1.60 - GuruFocus
B. Riley Financial Reaffirms Buy Rating for Hyperfine (NASDAQ:HYPR) - MarketBeat
HYPR Q2 2026 Earnings: Narrower-Than-Expected Loss Lifts Shares 2.83%EPS Growth Report - vinanet.vn
Hyperfine Q2 2026 slides: 45% revenue growth, AI-powered MRI expansion - Investing.com Australia
Hyperfine Inc (HYPR) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Hyperfine Touts Positive Results From Portable MRI Study - Medical Product Outsourcing
Hyperfine, Inc. Q2 2026 Earnings Call Summary - Yahoo Finance
Hyperfine (NASDAQ:HYPR) Announces Quarterly Earnings Results - MarketBeat
Hyperfine Q2 Earnings Call Highlights - MarketBeat
Earnings call transcript: Hyperfine’s Q2 2026 revenue rises 45% but misses estimates - Investing.com
Hyperfine, Inc. (HYPR) Reports Q2 Loss, Lags Revenue Estimates - Yahoo Finance
Hyperfine : Quarterly Report for Quarter Ending June 30, 2026 (Form 10-Q) - marketscreener.com
Hyperfine (HYPR) Releases Q2 2026 Earnings: Revenue Growth but EPS in Line - Quiver Quantitative
Hyperfine Q2 2026 earnings: Revenue rises 45% as operating loss narrows - TradingKey
Hyperfine, Inc. Q2 2026: Revenue $3.904M, EPS $(0.09) — 10-Q Summary - TradingView
Portable MRI maker Hyperfine's Q2 revenue rises less than expected - TradingView
Hyperfine, Inc. (HYPR) Q2 FY2026 earnings call transcript - Yahoo Finance
Hyperfine reports Q2 2026 revenue $3.9M, net loss $9.3M, expands international approvals - TradingView
Hyperfine Inc (HYPR) 재무 분석
매출
순이익
현금흐름
주당 순 이익
Hyperfine Inc 주식 (HYPR) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| HALE BRETT | CFO and CAO |
Aug 24 '26 |
Sale |
0.85 |
7,345 |
6,273 |
592,420 |
| HALE BRETT | CFO and CAO |
May 26 '26 |
Sale |
1.65 |
6,047 |
9,978 |
599,765 |
| TEISSEYRE THOMAS | Chief Operating Officer |
May 26 '26 |
Sale |
1.65 |
6,047 |
9,978 |
678,601 |
| TEISSEYRE THOMAS | Chief Operating Officer |
Mar 23 '26 |
Sale |
1.21 |
24,188 |
29,267 |
354,648 |
| HALE BRETT | CFO and CAO |
Mar 23 '26 |
Sale |
1.21 |
24,188 |
29,267 |
275,812 |
| TEISSEYRE THOMAS | Chief Operating Officer |
Feb 13 '26 |
Sale |
1.11 |
821 |
913 |
378,836 |
| TEISSEYRE THOMAS | Chief Operating Officer |
Nov 19 '25 |
Sale |
1.08 |
1,405 |
1,517 |
379,657 |
2.96%
8.16%
자본화:
|
볼륨(24시간):